| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial intelligence (AI) | 25.63 | 3279 |
| Intrinsic value (DCF) | 0.30 | -60 |
| Graham-Dodd Method | n/a | |
| Graham Formula | 9.84 | 1197 |
OneMedNet Corporation (NASDAQ: ONMD) is a pioneering healthcare technology company specializing in AI-driven clinical imaging solutions. Based in Eden Prairie, Minnesota, the company operates in the fast-growing healthcare information services sector, providing its proprietary iRWD platform to securely de-identify, search, and curate medical imaging data. This solution supports medical and academic research institutions in advancing diagnostics and life sciences research. OneMedNet's innovative approach leverages artificial intelligence to streamline data management, enhancing efficiency in medical research and discovery. With a focus on secure, scalable solutions, the company is well-positioned in the expanding digital healthcare market, where demand for AI-powered data analytics is rapidly increasing. Despite its early-stage financials, OneMedNet's niche in imaging data curation presents significant long-term potential as precision medicine and AI adoption accelerate in healthcare.
OneMedNet represents a high-risk, high-reward investment opportunity in the healthcare AI sector. The company's iRWD platform addresses a critical need in medical research—structured, de-identified imaging data—which could drive partnerships with pharmaceutical and academic institutions. However, with a market cap of just $12.5 million, negative EPS (-$0.36), and operating cash flow challenges (-$6.98M), the company remains speculative. Its low beta (0.762) suggests relative insulation from market volatility, but reliance on future funding and commercialization success poses risks. Investors should weigh its first-mover potential in imaging data curation against its current financial instability and the capital-intensive nature of AI healthcare solutions.
OneMedNet competes in the specialized niche of AI-curated medical imaging data, differentiating itself through its iRWD platform's focus on de-identification and search capabilities. Unlike broader healthcare IT players, ONMD's vertical-specific approach allows deeper integration with research workflows. However, the company faces competition from both established medical imaging giants and emerging AI startups. Its competitive edge lies in the proprietary technology for data curation, but scalability remains unproven. The lack of significant revenue ($643K in trailing figures) indicates it is still in customer acquisition phase, while larger rivals benefit from entrenched relationships. OneMedNet's asset-light model (minimal capex) is advantageous, but its high burn rate and debt ($8.76M) could limit R&D investment versus well-funded competitors. Success hinges on securing strategic partnerships to monetize its platform before cash reserves deplete.